News
Company news and developments, with original sources and dates.
Updated from source
Funding RSS ↗Octozi raises USD 3 million in seed financing
On 2026-07-11, according to Xiniu Data, Octozi completed seed financing, raising USD 3 million. Investors were lead investor Surface Ventures, participating investor Remarkable Ventures, participating investor Debiopharm Venture Arm. The company is a provider of AI medical services.
iRegene raises RMB 260 million in Series C+ financing
On 2026-07-02, according to Xiniu Data, iRegene completed Series C+ financing, raising RMB 260 million. Investors were lead investor Chengdu Ke Venture Capital, participating investor Zhongxinjian Investment Ben, participating investor Xi Venture Capital, participating investor Dingtaixing, participating investor Xinjiye, participating investor Hongyi Capital, participating investor Yuanxihaihe (Tianjin) Biotechnology Pharmaceutical Industry Fund Partnership (Limited Partnership). The company is a developer of chemically induced cell therapy drugs.
Warmly reaches USD 7.63 million ARR
On 2026/6/13, LinkedIn reported that US AI marketing platform Warmly had reached USD 7.63 million ARR as of 2026/5, growing 5% monthly and expecting USD 350 thousand net new revenue that month.
BioGeometry raises hundreds of millions of RMB in strategic financing
On 2026-06-09, according to Xiniu Data, BioGeometry completed strategic financing, raising hundreds of millions of RMB. Investors were co-lead investor Shanghai Biotechnology Pharmaceutical Innovation Zhuanhua Fund, co-lead investor Guoke Investment, co-lead investor Dachencaizhi, co-lead investor Xinglian Capital, participating investor Gaorong Capital, participating investor Zhishu Capital. The company is a provider of generative AI protein design platforms.
Armeta reaches USD 1.2 million in ARR three months after launch
On 2026/5/15, LinkedIn reported that Armeta, a US AI data platform for industrial engineering drawings, reached USD 1.2 million in ARR just three months after launch. The milestone was announced at Alchemist Accelerator's demo day.
Legacy Farmer expects 13 million to USD 15 million ARR
On 2026/5/10, LinkedIn reported that Legacy Farmer had disclosed projected ARR of 13 million to USD 15 million, rather than realized revenue. It did not disclose funding or valuation.
Shuyin Zhike raises tens of millions of USD in Pre-A funding
On 2026/4/29, Xiniu Data reported that Shuyin Zhike completed Pre-A funding worth tens of millions of USD. Cabio Biological Industry Investment (Wuhan) Co., Ltd. led the round, with other investors including Guangdong Kangrong Pharmaceutical Co., Ltd., Shanghai Grand NeoBay Ceyuan Venture Investment Partnership (Limited Partnership), and Ganzhou Guohui Runxin Venture Capital Fund (Limited Partnership). The company provides AI drug discovery services.
Iambic Therapeutics Acquired
On 2026-2-9, according to Xiniu Data, Iambic Therapeutics was acquired for USD 1.7 billion. Investors were Takeda Pharmaceutical Co.
Warmly reaches USD 6 million in ARR
On 2026/1/25, LinkedIn reported that Warmly disclosed annual recurring revenue (ARR) of USD 6 million in the AI Sales & Marketing sector.
Warmly founder discloses ARR surpassed USD 6 million in 2025/11
On 2025/12/31, Warmly co-founder Max Greenwald said in a post marking its sixth anniversary that Warmly had crossed USD 6 million ARR the previous month, 2025/11.
ServiceNow acquired Armis for $7.75B at $340M ARR
On 2026/10/7, Briefly reported that AI cybersecurity company Armis, with USD 340 million in annualized revenue, was acquired by ServiceNow for USD 7.75 billion. Its annualized revenue had grown 50% year over year.
Harmonic raises USD 120 million in Series C financing
Brief not available.
Gaowei Pharmaceutical raises tens of millions of RMB in strategic financing
Brief not available.
Shengshu Technology raises hundreds of millions of CNY in Series A led by Bohua Capital
On 2025/9/19, Securities Times reported that Shengshu Technology had raised hundreds of millions of CNY in Series A funding led by Bohua Capital, with follow-on participation from existing investors including Baidu’s strategic investment arm and Qiming Venture Partners.
DataCrunch raises USD 64 million in Series A funding; valuation, employee count, and revenue are not mentioned
On 2025/9/8, ain.ua reported that Helsinki-based high-performance AI infrastructure provider DataCrunch raised USD 64 million in Series A funding, co-led by byFounders, Skaala, Varma, and Tesi, bringing total funding to USD 64 million. Founded by Luiza Chekurda, it aims to become the first AI cloud hyperscaler in Europe.
Armis exceeds USD 300 million annual revenue as cybersecurity demand surges
On 2025/8/4, Armis officially reported that the IoT security company had exceeded USD 300 million in annual recurring revenue, growing from USD 200 million to its current scale in under 12 months. Customers included thousands of enterprises such as United Airlines, Crest and Mars, covering more than a third of the Fortune 100.
Harmonic raises USD 100 million in Series B financing
Brief not available.
Orion Arm raises USD 11 million in Series A financing
Brief not available.
Founders Arm reaches USD 1 million ARR
On 2025/6/22, ARR Club reported that Founders Arm had disclosed USD 1 million in annual recurring revenue. It provides funding connections and pitch resources for entrepreneurs.
Halter reaches USD 34 million ARR
On 2025/5/30, ARR Club reported that New Zealand farm management platform Halter had disclosed USD 34 million in annual recurring revenue. Its smart collars and automated grazing system help dairy farmers manage herds.
Jiashiteng Pharma completes strategic investment financing
On 2025-3-3, according to Xiniu Data, Jiashiteng Pharma completed strategic investment financing
80 Acres Farms raises USD 115 million in Series C financing
Brief not available.
Instantly reaches USD 20 million ARR
On 2025/2/10, LinkedIn reported that US cold email outreach platform Instantly had disclosed USD 20 million in annual recurring revenue. It provides sales teams with bulk email sending and warmed mailbox management, with ARR growing rapidly from USD 2.4 million at the beginning of 2023.
Huixian Pharmaceutical completes strategic financing
Brief not available.